Maxigen Biotech Inc. announced the appointment of Lin Yung-Hsiang, Liao Sung-Yuan, Li Shi Ming, Zeng Zhong Ming and Chen Ching-Ting to the newly formed risk management committee effective as on May 3, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.6 TWD | +0.83% | +1.55% | -11.98% |
05-06 | Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-11.98% | 117M | |
+19.86% | 20.82B | |
0.00% | 19.12B | |
+20.01% | 12.79B | |
-19.36% | 8.81B | |
+29.10% | 8.38B | |
+11.17% | 6.02B | |
-10.48% | 3.96B | |
-17.26% | 3.88B | |
-0.71% | 3.83B |
- Stock Market
- Equities
- 1783 Stock
- News Maxigen Biotech Inc.
- Maxigen Biotech Inc. Appoints Members of the Company's Risk Management Committee